Tiago Bordeira Gaspar

Prof. Dr. Tiago Bordeira Gaspar

i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
+3
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2018 in Genes
Verified
Journal Article
Open access
PDF file
Tiago Bordeira GasparTiago Bordeira Gaspar
Tiago Bordeira Gaspar
ASAna Sá
Ana Sá
José Manuel LopesJosé Manuel Lopes
José Manuel Lopes
MSManuel Sobrinho-Simões
Manuel Sobrinho-Simões
Paula SoaresPaula Soares
Paula Soares
JVJoão Vinagre
João Vinagre
Tumour cells can adopt telomere maintenance mechanisms (TMMs) to avoid telomere shortening, an inevitable process due to successive cell divisions. In most tumour cells, telomere length (TL) is maintained by reactivation of telomerase, while a small part acquires immortality through the telomerase-independent alternative lengthening of telomeres (ALT) mechanism. In the last years, a great amount of data was generated, and different TMMs were reported and explained in detail, benefiting from genome-scale studies of major importance. In this review, we address seven different TMMs in tumour cells: mutations of the TERT promoter (TERTp), amplification of the genes TERT and TERC, polymorphic variants of the TERT gene and of its promoter, rearrangements of the TERT gene, epigenetic changes, ALT, and non-defined TMM (NDTMM). We gathered information from over fifty thousand patients reported in 288 papers in the last years. This wide data collection enabled us to portray, by organ/system and histotypes, the prevalence of TERTp mutations, TERT and TERC amplifications, and ALT in human tumours. Based on this information, we discuss the putative future clinical impact of the aforementioned mechanisms on the malignant transformation process in different setups, and provide insights for screening, prognosis, and patient management stratification.

1 March 2021 in Metabolism
Verified
Journal Article
Open access
JSJelena Stevanović-Silva
Jelena Stevanović-Silva
JBJorge Beleza
Jorge Beleza
PCPedro Coxito
Pedro Coxito
Susana P. PereiraSusana P. Pereira
Susana P. Pereira
HRHugo Rocha
Hugo Rocha
JMJosé Magalhães
José Magalhães
Maternal high-caloric nutrition and related gestational diabetes mellitus (GDM) are associated with a high-risk for developing metabolic complications later in life and in their offspring. In contrast, exercise is recognized as a non-pharmacological strategy against metabolic dysfunctions associated to lifestyle disorders. Therefore, we investigated whether gestational exercise delays the development of metabolic alterations in GDM mothers later in life, but also protects 6-week-old male offspring from adverse effects of maternal diet. Female Sprague-Dawley rats were fed with either control (C) or high-fat high-sucrose (HFHS) diet to induce GDM and submitted to gestational exercise during the 3 weeks of pregnancy. Male offspring were sedentary and fed with C-diet. Sedentary HFHS-fed dams exhibited increased gestational body weight gain (p < 0.01) and glucose intolerance (p < 0.01), characteristic of GDM. Their offspring had normal glucose metabolism, but increased early-age body weight, which was reverted by gestational exercise. Gestational exercise also reduced offspring hepatic triglycerides accumulation (p < 0.05) and improved liver mitochondrial respiration capacity (p < 0.05), contributing to the recovery of liver bioenergetics compromised by maternal HFHS diet. Interestingly, liver mitochondrial respiration remained increased by gestational exercise in HFHS-fed dams despite prolonged HFHS consumption and exercise cessation. Gestational exercise can result in liver mitochondrial adaptations in GDM animals, which can be preserved even after the exercise program cessation. Exposure to maternal GDM programs liver metabolic setting of male offspring, whereas gestational exercise appears as an important preventive tool against maternal diet-induced metabolic alterations.

1 March 2019 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
PDF file
BPBegoña Pérez-Cabezas
Begoña Pérez-Cabezas
PCPedro Amado Cecilio
Pedro Amado Cecilio
Tiago Bordeira GasparTiago Bordeira Gaspar
Tiago Bordeira Gaspar
FGFátima Gärtner
Fátima Gärtner
RVRita Vasconcellos
Rita Vasconcellos
Anabela Cordeiro-Da-SilvaAnabela Cordeiro-Da-Silva
Anabela Cordeiro-Da-Silva
Every year, up to 90,000 new cases of Visceral Leishmaniasis and 30,000 resultant deaths are estimated to occur worldwide. Such numbers give relevance to the continuous study of this complex form of the disease: a zoonosis and an anthroponosis; two known etiological agents (Leishmania infantum and L. donovani, respectively); with an estimated average ratio of 1 symptomatic per 10 asymptomatic individuals; and sometimes associated with atypical clinical presentations. This complexity, which results from a long co-evolutionary process involving vector-host, host-pathogen, and pathogen-vector interactions, is still not completely understood. The determinants of visceralization are not fully defined and the dichotomy resistance vs. susceptibility remains unsolved, translating into obstacles that delay the progress of global disease control. Inbred mouse models, with different susceptibility patterns to Leishmania infection, have been very useful in exploring this dichotomy. BALB/c and C57BL/6 mice were described as susceptible strains to L. donovani visceral infection, while SV/129 was considered resistant. Here, we used these three mouse models, but in the context of L. infantum infection, the other Leishmania species that cause visceral disease in humans, and dynamically compared their local and systemic infection-induced immune responses in order to establish a parallel and to ultimately better understand susceptibility vs. resistance in visceral leishmaniasis. Overall, our results suggest that C57BL/6 mice develop an intermediate “infection-phenotype” in comparison to BALB/c and SV/129 mouse strains, considering both the splenic parasite burden and the determined target organs weights. However, the immune mechanisms associated with the control of infection seem to be different in each mouse strain. We observed that both BALB/c and SV/129, but not C57BL/6 mice, show an infection-induced increase of splenic T follicular helper cells. On the other hand, differences detected in terms of CD21 expression by B cells early after infection, together with the quantified anti-Leishmania specific antibodies, suggest that SV/129 are faster than BALB/c and C57BL/6 mice in the assembly of an efficient B-cell response. Additionally, we observed an infection-induced increase in polyfunctional CD4+ T cells in the resistant SV/129 model, opposing an infection-induced increase in CD4+IL-10+ cells in susceptible BALB/c mice. Our data aligns with the observations reported for L. donovani infection and suggest that not only a single mechanism, but an interaction of several could be necessary for the control of this parasitic disease.

20 March 2017 in Veterinary and Comparative Oncology
Verified
Journal Article
Closed access
PDF file
Tiago Bordeira GasparTiago Bordeira Gaspar
Tiago Bordeira Gaspar
JHJoaquim Henriques
Joaquim Henriques
LMLaura Marconato
Laura Marconato
FQFelisbina Luisa Queiroga
Felisbina Luisa Queiroga

18 September 2017 in Discover Oncology
Verified
Journal Article
Closed access
PDF file
HPHelena Pópulo
Helena Pópulo
BNBruno Nunes
Bruno Nunes
CSCristina Sampaio
Cristina Sampaio
RBRui Batista
Rui Batista
MPMarta Pinto
Marta Pinto
Paula SoaresPaula Soares
Paula Soares

1 February 2020 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
PRPaula Rodrigues-Pereira
Paula Rodrigues-Pereira
Sofia MacedoSofia Macedo
Sofia Macedo
Tiago Bordeira GasparTiago Bordeira Gaspar
Tiago Bordeira Gaspar
Sule CANBERKSule CANBERK
Sule CANBERK
SSSamia Selmi-Ruby
Samia Selmi-Ruby
Leandro Miranda-AlvesLeandro Miranda-Alves
Leandro Miranda-Alves